GPN Vaccines’ Post

AstraZeneca has announced the global discontinuation of its COVID-19 vaccine, Vaxzevria, citing a surplus of newer vaccine options amid the pandemic. This decision follows a decline in demand for the vaccine, which is no longer being manufactured or supplied. The move comes in the wake of reports linking the vaccine, developed with the University of Oxford, to rare cases of Thrombosis with Thrombocytopenia Syndrome (TTS), a blood clot-related side effect. Meanwhile, Bharat Biotech, amidst concerns over the AstraZeneca vaccine, released a statement affirming the safety of its Covaxin. In India, where the AstraZeneca vaccine is marketed as Covishield, legal action has been initiated against the Serum Institute of India (SII), which produces Covishield. A plea has been submitted to the Supreme Court, urging the establishment of a medical expert panel to investigate Covishield's side effects and risks, as well as the creation of a vaccine damage payment system for those severely affected. This legal action follows the tragic death of Karunya, who passed away in July 2021 after receiving the Covishield vaccine. With over 1.75 billion doses of Covishield administered in India, concerns over adverse reactions have intensified. Advocate Vishal Tiwari, representing the plaintiffs, highlighted an increase in deaths attributed to heart attacks and sudden collapses post-vaccination. SII now faces legal scrutiny as families seek accountability for vaccine-related incidents. #astrazeneca #covıd #covi̇d19 #vaccine #worldwide #safety #university #oxford #cases #thrombosis #tts #incidents #families #scrutiny #heartattacks #death #plaintiffs #vishaltiwari #thecordbharat

TRUTH WILL COME OUT: SUPPORT WHISTLEBLOWERS... AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers The jab, developed by Oxford University, can no longer be used in the European Union after the company voluntarily withdrew its 'marketing authorisation', coming into effect today. Similar applications to withdraw the vaccine will be made in other countries that had previously approved it, including the UK. Australia's Therapeutic Goods Authority discontinued use of the vaccine in April 2023. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. When will the truth come out in MSM about the other variations of an injection that keeps killing people and getting promoted. Any thoughts good or bad. Did the vaccine save your life? Tell us about it Did it harm you? Tell us about it #c19 #pandemic #australia #uk #usa #china

British pharmaceutical giant AstraZeneca has shockingly acknowledged in court documents that its COVID-19 vaccine, Covishield, can cause a rare but serious condition known as Thrombosis with Thrombocytopenia Syndrome (TTS). This condition leads to blood clots and a low platelet count, posing significant health risks. This admission came to light during a class action lawsuit in the UK, where victims are seeking up to £100 million in damages for deaths and severe injuries allegedly caused by the vaccine. One of the claimants, Jamie Scott, reported suffering a permanent brain injury due to a blood clot after receiving the vaccine in April 2021, which dramatically affected his ability to work and nearly resulted in his death. Despite AstraZeneca's previous stance in 2023, where they denied a generic causal link between the vaccine and TTS, recent court filings indicate an acceptance of the possibility of such side effects occurring, although they emphasized that TTS can also occur independently of vaccination. The company maintains that whether the vaccine caused TTS in specific individuals will require expert testimony. In response to the allegations, AstraZeneca has defended the integrity and efficacy of the Covishield vaccine, disputing claims that it is "defective" or that its benefits were "vastly overstated." However, the acknowledgment in court marks a significant shift in the narrative surrounding the vaccine's safety profile. The controversy surrounding Covishield led to its suspension or outright ban in several countries worldwide, including Denmark, Ireland, Thailand, and Canada, among others, primarily due to reported cases of blood clots post-vaccination. The World Health Organization (WHO) has continued to recommend the AstraZeneca vaccine, stating that its benefits outweigh the risks and urging that vaccinations proceed. Nonetheless, the ongoing legal challenges and AstraZeneca's admission highlight the complexities and responsibilities of vaccine manufacturers in addressing potential adverse effects. . . . #TheTatva #TatvaNews #India #UK #British #Vaccine #COVID19 #Astrazeneca #COvishield #Health #Medical #Hospital #Lawsuit #Blood #Legal #WHO

The November 2023 coalition agreements promised that medicines approved by at least two trustworthy countries' regulators would be automatically approved in NZ within 30 days. Jynneos, the vaccine for Monkeypox (mpox) was approved in Canada four years ago. EMA and FDA in 2022. Nobody applied for NZ approval until 2023. NZ is a small market at the far end of the world. Medsafe imposes too much bespoke hassle to make this small market anyone's priority. Medsafe took a year and a half to approve the mpox vaccine, approving it the day after a pile of cases were notified from the Queenstown Pride Festival. All of this is stupid. Medsafe adds negative value through delaying safe medicines. And access to unapproved medicines through S29 of the Medicines Act is just too cumbersome for medicines like the mpox vaccine. Our Vogons made it illegal to advertise a monkeypox vaccine to at-risk communities before the Pride festival, and illegal for anyone other than a GP to dispense it. My column at Newsroom. The incoming government promised they'd fix this: it's in both coalition agreements. Medsafe still took 18 months. https://lnkd.in/guta2w7d

📢 Valneva has received approval from Health Canada for its chikungunya vaccine, IXCHIQ®. 🩺 The vaccine is the world's first licensed vaccine for the prevention of chikungunya disease. 💉 The vaccine is a single-dose vaccine for individuals 18 years and older. 🌍 Valneva plans to sell the first doses in Canada in the fourth quarter of 2024. 🌐 The vaccine addresses an unmet medical need as millions of people travel to chikungunya-endemic countries each year. 🌡️ Valneva has also received approval from the US Food and Drug Administration and awaits approval from the European Medicines Agency. #BioprocessUpdates #ChikungunyaVaccine #HealthCanadaApproval #Valneva #IXCHIQ #WorldsFirst #SingleDoseVaccine #Prevention #UnmetMedicalNeed #TravelSafety #FourthQuarter2024 #FDAApproval #EMAApproval #ChikungunyaDisease #PublicHealth #MedicalBreakthrough ▷ Read the full article here: 📎 https://lnkd.in/d-Gyn7hq

The Covid inquiry will not start hearing evidence about the development of vaccines and other drugs this summer, as originally planned. Witness hearings will be postponed until a later date, likely to be after the next general election... I wonder why? Even though the Tories are pretty clearly going to lose the next election, they are still trying everything to save their seats. They now want the next stage of the inquiry to focus on Covid's impact on the NHS, simply so they can blame our failing healthcare system on a pandemic, not mismanagement. They know what will be found in this inquiry. They know the public will discover the vaccines were nowhere near as effective as first claimed. We will realise the vaccines were nowhere near as safe as first claimed. And worst of all, it'll probably come out that most of us didnt need the vaccine at all. My guess is that we will also learn we could have used much cheaper therapeutics, but instead chose the vaccine at a cost of £12+ billion. I'm not anti-vax... I've put much worse into my body voluntarily. I'm simply saying, this part of the inquiry is actually the most important part because its all about what we were forced to put into our bodies, and yet they cant find time for it.

This is the best example of why we should ban Children's Health Defense must be banned from LinkedIn. Not only are their post false in facts, but it is false in conclusions. First, Protocol 7 is pure fantasy far from the truth of the case. Second, MMR II vaccines never had the extent of failures Children's Health Defense is here claiming. There is no data to support such claim, and their technique of quoting the NEJM and being linked to a court document is fallacious and a lie. Third, any claim of increased autism linked to any MMR vaccines is pure lie, heresy, hypocrisy, and has been debunked so many times that putting up such claim is criminal. And hosting such is as well… LinkedIn is being put on notice of immediately removing this Children's Health Defense post or exposed to litigation in supporting such lie that go against their own policy. @linkedin, please act swiftly and accordingly… Anthony D. Cox, Ph.D. Michael Falk Dorit Reiss might want to contribute here…

https://lnkd.in/eF-RtiPh Vaccines are arguably more extensively monitored for safety following licensure than therapeutic medicinal products, with reliable systems in place to promptly detect very rare adverse events. This intriguing article highlights an opportunity to further enhance federal vaccine safety monitoring through reallocating funds that are already being collected through the Vaccine Injury Compensation Program (VICP, 1986). The authors lay out practical recommendations for implementation and provide the welcome information that the proposal fully preserves the VICP while being budget neutral.

Formaldehyde is used in the production of vaccines. Let's understand how it plays such an important role. Source: U.S. Food & Drug Administration Link: https://lnkd.in/gewsnsqe #Vaccines #Formaldehyde #VaccineIngredients #FDA #HealthSafety #PublicHealth #Immunization #VaccineSafety #Biologics #MedicalScience #FDAApproved #ChemicalSolutions #chemical #chemicalmanufacturer #manufacturingindustry #Indiasleadingsupplier #Balajiformalin #Burakiagroup